Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04265430 · ClinicalTrials.gov registry record · Phase 4

Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors

A Phase 4 study of Osteoradionecrosis and Malignant Oral Cavity Neoplasm, sponsored by M.D. Anderson Cancer Center.

Recruiting
Registry status
Phase 4
Development phase
425
Enrollment target
1
Study location

NCT04265430 is a Phase 4 study of Osteoradionecrosis and Malignant Oral Cavity Neoplasm that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 425 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04265430, a Phase 4 study of Osteoradionecrosis and Malignant Oral Cavity Neoplasm, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.

RECRUITING
Registry status
Phase 4
Development phase
425 participants
Enrollment target
1
Study location

Study Summary

This phase IV trial studies how well serial magnetic resonance imaging (MRI) after radiation therapy works in predicting radiation-induced changes in the normal tissue of patients with oral cavity or skull base tumors. Performing MRIs after radiation therapy for patients with oral cavity or skull base tumors may help to predict osteoradionecrosis (a change in non-cancerous tissue).

Interventions

  • OTHER Quality-of-Life Assessment
  • PROCEDURE Magnetic Resonance Imaging
  • OTHER Questionnaire Administration
  • OTHER Contrast Agent

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 425 participants
Start Date 2018-09-17
Est. Completion 2031-09-01
Phase Phase 4

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT04265430

The ClinicalTrials.gov registry entry for NCT04265430 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 425 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Osteoradionecrosis appearing as the primary indexed condition, and to 4 interventions - of which Quality-of-Life Assessment is the first listed.

NCT04265430 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04265430 about?

NCT04265430 is a clinical study titled "Serial Magnetic Resonance Imaging for the Prediction of Radiation-Induced Changes in Normal Tissue of Patients With Oral Cavity or Skull Base Tumors". This phase IV trial studies how well serial magnetic resonance imaging (MRI) after radiation therapy works in predicting radiation-induced changes in the normal tissue of patients with oral cavity or skull base tumors. Performing MRIs after radiation therapy for patients with oral cavity or skull ba...

What is the current status of trial NCT04265430?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 425 participants. The study started on 2018-09-17. Estimated completion is 2031-09-01.

What conditions does trial NCT04265430 study?

This clinical trial studies the following conditions: Osteoradionecrosis, Malignant Oral Cavity Neoplasm, Malignant Skull Base Neoplasm.

What interventions are being tested in trial NCT04265430?

The interventions under investigation include: Quality-of-Life Assessment (OTHER), Magnetic Resonance Imaging (PROCEDURE), Questionnaire Administration (OTHER), Contrast Agent (OTHER).

Who is sponsoring clinical trial NCT04265430?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04265430 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoradionecrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.